With support from the US Centers for Disease Control and Prevention, DC’s public health agencies and healthcare facilities will examine the occurrence of “superbugs” in a first-of-its-kind citywide evaluation.
University of Utah chemists have discovered a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
Early data suggests the test’s clinical potential for guiding anti-PD-1 therapy.
The Defense Health Agency has added 32 tests to its demonstration project reviewing tests not examined by FDA to determine whether they are safe and effective for use.
The fully automated hematoxylin and eosin tissue staining system eliminates the use of xylene and alcohol, reducing technician exposure to harmful chemicals.
The chip enables researchers to use droplet-based microfluidic methods to help explore the behavior of thousands of individual cells, providing a rapid and easy way to screen for new or cryptic cell types.
The assay enables rapid assessment of tissue-based biomarker expression across the full spectrum of clinical formalin-fixed, paraffin-embedded tissue samples without the need for lengthy rounds of assay optimization.
For the coming year, labs are expecting more regulatory challenges amid advancing technologies.
Launched in October, the program provides the essential first steps of a comprehensive approach to address the shortage of qualified laboratory professionals in the healthcare industry.
Qiagen developed GeneReader as a complete sample-to-insight next-generation sequencing solution, designed for any lab to deliver actionable results.
The system’s latest launch includes an advanced hematology module that offers improved visibility of critical data.
The biennial ASCP vacancy survey has captured a profession in transition.
The reconfigured membrane chromatography capsules aim to more effectively recover large molecular weight proteins, such as blood factors and conjugated proteins.
Designed with cost-savings and functionality in mind, the company’s chemistry and reagent device permits all assay steps to be performed within a fully enclosed cartridge.
The closed-tube, scalable, 96-well based system from Luminex seeks to meet clinical demand for respiratory disease testing.
Following best practices can help labs maximize the utility and cost-effectiveness of flu testing.
CLP's November Tech Guide features cardiovascular probes, reagents, and assays from companies such as Beckman Coulter Inc, Diazyme Laboratories, Roche Diagnostics, and Siemens Point of Care Diagnostics.
According to US Centers for Disease Control and Prevention, a comprehensive and timely overview of influenza activity is an essential public health activity for a variety of reasons.
The fully automated Cobas 6800 and 8800 systems aim to introduce a new standard for routine molecular testing in the areas of viral load monitoring, donor screening, women’s health, and microbiology.
The main filter can be chosen from 14 different types of carbon, which include specialty media for vapors of acids, formaldehyde, organics, mercury, and solvents.